Associations between radiological parameters and molecular phenotype in human GH-secreting pituitary tumours: could they help in predicting the appropriate medical therapy?
María Rosa Alhambra-Expósito(Instituto Maimónides de Investigación Biomédica de Córdoba), Justo Castano-Pastor, Raul Miguel Luque-Huertas, Maria Sagrario Lombardo-Galera, María Ángeles Gálvez-Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition)
Cited by 0
Related Papers
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
|Cancer Letters|2015|91
Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight
|Journal of Endocrinology|2013|88
A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications
|The Journal of Clinical Endocrinology & Metabolism|2013|81
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro
|Journal of Endocrinology|2016|74
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
|Scientific Reports|2015|60